| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 71 | $295.89 | $21,008.19 | -0.1% | → |
| 2023-02-14 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 800 | $295.79 | $236,632.00 | -1.5% | → |
| 2023-02-13 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 275 | $298.99 | $82,222.87 | - | → |
| 2023-02-13 | Arbuckle Stuart A | EVP, COO | Sell | 4,887 | $298.92 | $1,460,815.65 | -1.4% | → |
| 2023-02-13 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 4,798 | $298.90 | $1,434,126.48 | -2.1% | → |
| 2023-02-13 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 113 | $300.39 | $33,944.07 | -0.2% | → |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO | Sale+OE | 1,304 | $306.00 | $399,021.78 | -0.3% | → |
| 2023-01-31 | SACHS BRUCE I | Director | Sale+OE | 1,200 | $325.01 | $390,012.00 | -2.8% | → |
| 2023-01-31 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 106 | $325.00 | $34,450.00 | -0.3% | → |
| 2023-01-30 | CARNEY LLOYD | Director | Sell | 2,700 | $320.52 | $865,406.24 | -16.1% | → |
| 2023-01-27 | Lee Yuchun | Director | Sale+OE | 1,429 | $322.03 | $460,176.89 | -17.5% | → |
| 2023-01-26 | Lee Yuchun | Director | Sale+OE | 8,000 | $316.15 | $2,529,174.49 | -20.9% | → |
| 2023-01-25 | Kewalramani Reshma | CEO & President | Sell | 10,000 | $315.05 | $3,150,500.00 | -10.0% | → |
| 2023-01-24 | Lee Yuchun | Director | Sale+OE | 6,129 | $312.46 | $1,915,043.81 | -46.3% | → |
| 2023-01-18 | Lee Yuchun | Director | Sale+OE | 4,442 | $312.04 | $1,386,099.14 | -54.2% | → |
| 2022-11-15 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 34 | $308.61 | $10,492.74 | - | → |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO | Sale+OE | 940 | $302.87 | $284,697.92 | -0.6% | → |